@article{Bonnet2022,
abstract = {Background: Tuberculous meningitis (TBM) is the most lethal and disabling form of tuberculosis (TB) particularly in sub-Saharan Africa. Current anti-TB treatment is poorly effective since TBM mortality reaches 40{\%} in HIV negative patients and up to 70{\%} in HIV co-infected patients. To reduce TBM induced morbidity and mortality, the INTENSE-TBM trial evaluates two},
author = {Bonnet, Fabrice},
doi = {10.21203/RS.3.RS-1941581/V1},
file = {:C$\backslash$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Bonnet - 2022 - Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis men.pdf:pdf},
journal = {Research Square},
keywords = {Aspirin,HIV,High-dose rifampicin,Linezolid,OA,Randomized Controlled Trial,Tuberculous meningitis,fund{\_}ack,protocol},
mendeley-tags = {OA,fund{\_}ack,protocol},
month = {sep},
pages = {doi.org/10.21203/rs.3.rs--1941581/v1},
title = {{Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): Study protocol for a Phase III Randomized Controlled Trial}},
url = {https://www.researchsquare.com https://www.researchsquare.com/article/rs-1941581/v1},
year = {2022}
}

{"_id":"Gj6YoStwurBXM2AW7","bibbaseid":"bonnet-intensifiedtuberculosistreatmenttoreducethemortalityofhivinfectedanduninfectedpatientswithtuberculosismeningitisintensetbmstudyprotocolforaphaseiiirandomizedcontrolledtrial-2022","author_short":["Bonnet, F."],"bibdata":{"bibtype":"article","type":"article","abstract":"Background: Tuberculous meningitis (TBM) is the most lethal and disabling form of tuberculosis (TB) particularly in sub-Saharan Africa. Current anti-TB treatment is poorly effective since TBM mortality reaches 40% in HIV negative patients and up to 70% in HIV co-infected patients. To reduce TBM induced morbidity and mortality, the INTENSE-TBM trial evaluates two","author":[{"propositions":[],"lastnames":["Bonnet"],"firstnames":["Fabrice"],"suffixes":[]}],"doi":"10.21203/RS.3.RS-1941581/V1","file":":C$\\$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Bonnet - 2022 - Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis men.pdf:pdf","journal":"Research Square","keywords":"Aspirin,HIV,High-dose rifampicin,Linezolid,OA,Randomized Controlled Trial,Tuberculous meningitis,fund_ack,protocol","mendeley-tags":"OA,fund_ack,protocol","month":"sep","pages":"doi.org/10.21203/rs.3.rs–1941581/v1","title":"Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): Study protocol for a Phase III Randomized Controlled Trial","url":"https://www.researchsquare.com https://www.researchsquare.com/article/rs-1941581/v1","year":"2022","bibtex":"@article{Bonnet2022,\r\nabstract = {Background: Tuberculous meningitis (TBM) is the most lethal and disabling form of tuberculosis (TB) particularly in sub-Saharan Africa. Current anti-TB treatment is poorly effective since TBM mortality reaches 40{\\%} in HIV negative patients and up to 70{\\%} in HIV co-infected patients. To reduce TBM induced morbidity and mortality, the INTENSE-TBM trial evaluates two},\r\nauthor = {Bonnet, Fabrice},\r\ndoi = {10.21203/RS.3.RS-1941581/V1},\r\nfile = {:C$\\backslash$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Bonnet - 2022 - Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis men.pdf:pdf},\r\njournal = {Research Square},\r\nkeywords = {Aspirin,HIV,High-dose rifampicin,Linezolid,OA,Randomized Controlled Trial,Tuberculous meningitis,fund{\\_}ack,protocol},\r\nmendeley-tags = {OA,fund{\\_}ack,protocol},\r\nmonth = {sep},\r\npages = {doi.org/10.21203/rs.3.rs--1941581/v1},\r\ntitle = {{Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): Study protocol for a Phase III Randomized Controlled Trial}},\r\nurl = {https://www.researchsquare.com https://www.researchsquare.com/article/rs-1941581/v1},\r\nyear = {2022}\r\n}\r\n","author_short":["Bonnet, F."],"key":"Bonnet2022","id":"Bonnet2022","bibbaseid":"bonnet-intensifiedtuberculosistreatmenttoreducethemortalityofhivinfectedanduninfectedpatientswithtuberculosismeningitisintensetbmstudyprotocolforaphaseiiirandomizedcontrolledtrial-2022","role":"author","urls":{"Paper":"https://www.researchsquare.com https://www.researchsquare.com/article/rs-1941581/v1"},"keyword":["Aspirin","HIV","High-dose rifampicin","Linezolid","OA","Randomized Controlled Trial","Tuberculous meningitis","fund_ack","protocol"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://drive.google.com/uc?export=download&id=1-JLqZ7RwZ3VC2d6ErLGHAtOeMRS_7GCz","dataSources":["Krmt6gt9ktB2s6ARh"],"keywords":["aspirin","hiv","high-dose rifampicin","linezolid","oa","randomized controlled trial","tuberculous meningitis","fund_ack","protocol"],"search_terms":["intensified","tuberculosis","treatment","reduce","mortality","hiv","infected","uninfected","patients","tuberculosis","meningitis","intense","tbm","study","protocol","phase","iii","randomized","controlled","trial","bonnet"],"title":"Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): Study protocol for a Phase III Randomized Controlled Trial","year":2022}